Table 3.
Quantitative composition of microbiota in patients with mixed invasion.
| Groups of microorganisms | Number of microorganisms, lg CFU/g, M±m | |||
|---|---|---|---|---|
| Before treatment (n=30) | After treatment | Control group (n=20) | ||
| 3a group (n=15) | 3b group (n=15) | |||
| Bifidobacterium spp. | 4.61±0.19* | 6.93±0.27** # | 7.93±0.22*** | 8.05±0.15 |
| Lactobacillus spp. | 4.57±0.20* | 6.79±0.19** # | 7.64±0.23*** | 8.10±0.18 |
| Peptostreptococcus spp. | 8.11±0.29* | 6.21±0.15 | 5.86±0.18 | 5.65±0.20 |
| Bacteroides spp. | 9.71±0.22* | 7.93±0.37** # | 7.07±0.22*** | 6.85±0.20 |
| E. coli (total) | 5.11±0.17* | 6.57±0.17** # | 7.21±0.21*** | 7.50±0.20 |
| Weak ferm. E. coli | 1.32±0.15* | 1.07±0.13** # | 0.57±0.14*** | 0.45±0.11 |
| Hemolytic E. coli | 2.21±0.25* | 0.57±0.14** # | 0.14±0.10*** | 0 |
| Enterococcus spp. | 5.75±0.20* | 6.93±0.25** # | 7.64±0.23*** | 7.95±0.14 |
| Opportunistic Enterobacteriaceae spp. | 7.11±0.36* | 5.21±0.21** # | 4.21±0.21*** | 4.05±0.27 |
| Candida spp. | 5.32±0.33* | 2.86±0.35** # | 1.36±0.20*** | 1.25±0.18 |
| Staphylococcus spp. | 3.96±0.20* | 2.64±0.31 | 2.36±0.20 | 2.20±0.12 |
*
– p<0.05 the reliability of the difference between the similarity indicators between the group before treatment and the control group; ** – p<0.05 the reliability of the difference between the similar indicators between the group before treatment and the 3a group; *** – p<0.05 the reliability of the difference between the similar indicators between the group before treatment and the 3b group; # – p<0.05 the reliability of the difference between the similar indicators between the 3a and 3b groups.